Skip to main content
Top

Breast Cancer

Issue 1/2019

Content (14 Articles)

Review Article

Axillary reverse mapping (ARM): where to go

Xuan Shao, Bo Sun, Yanwen Shen

Review Article

CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis

Ayesha Aftab, Shaheen Shahzad, Hafiz Muhammad Jafar Hussain, Ranjha Khan, Samra Irum, Sobia Tabassum

Review Article

Exposure to violence in breast cancer patients: systematic review

Dilek Aygin, Havva Bozdemir

Original Article

Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study

Emi Noguchi, Kenji Tamura, Masaya Hattori, Jun Horiguchi, Nobuaki Sato, Kazumitsu Kanatani, Kiyoshi Matsunaga, Hiroji Iwata, Yasuhiro Fujiwara

Open Access Original Article

CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy

Eriko Tokunaga, Aya Fujita, Katsumi Takizawa, Kimiko Baba, Sayuri Akiyoshi, Yoshiaki Nakamura, Hideki Ijichi, Takanobu Masuda, Chinami Koga, Wakako Tajiri, Shinji Ohno, Kenichi Taguchi, Mayumi Ishida

Original Article

Quantitative assessment and risk factors for nipple–areolar complex malposition after nipple-sparing mastectomy

Takaya Makiguchi, Hideharu Nakamura, Takaaki Fujii, Satoshi Yokoo

Open Access Original Article

Effects of a combined exercise plus diet program on cardiorespiratory fitness of breast cancer patients

K. Okumatsu, T. Tsujimoto, K. Wakaba, A. Seki, R. Kotake, T. Yamauchi, S. Hirayama, H. Kobayashi, H. Yamauchi, K. Tanaka

Correction

Correction to: Effects of a combined exercise plus diet program on cardiorespiratory fitness of breast cancer patients

K. Okumatsu, T. Tsujimoto, K. Wakaba, A. Seki, R. Kotake, T. Yamauchi, S. Hirayama, H. Kobayashi, H. Yamauchi, K. Tanaka

Original Article

Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer

Dachang Ma, Cheng Chen, Jun Wu, Honglei Wang, Duoming Wu

Original Article

Oncoplastic approach to excisional breast biopsies: a randomized controlled, phase 2a trial

Volkan Doğru, Muhittin Yaprak, Emel Durmaz, Özlenen Özkan, Ayhan Mesci, Ömer Özkan, Vahit Özmen, Cumhur Arıcı

Original Article

Quantitative proteome and lysine succinylome analyses provide insights into metabolic regulation in breast cancer

Chenchen Liu, Ying Liu, Lei Chen, Mingjun Zhang, Wei Li, Huaidong Cheng, Bo Zhang

Original Article

Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results

Katsuhiko Nakatsukasa, Hiroshi Koyama, Yoshimi Ouchi, Hisako Ono, Kouichi Sakaguchi, Takayuki Matsuda, Makoto Kato, Takashi Ishikawa, Kimito Yamada, Mana Yoshimura, Kei Koizumi, Teruhisa Sakurai, Hideo Shigematsu, Shunji Takahashi, Shinichiro Taira, Masato Suzuki, Kazutaka Narui, Naoki Niikura, Yoshie Hasegawa, Daishu Miura, Eiichi Konishi, Tetsuya Taguchi

Original Article

Fat necrosis after breast-conserving oncoplastic surgery

Haruka Nakada, Masayuki Inoue, Kazushige Furuya, Hideki Watanabe, Kou Ikegame, Yuko Nakayama, Masato Ohmori, Hiroshi Nakagomi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine